I

Immuron Limited
D

IMRN

1.89000
USD
-0.09
(-4.55%)
مفتوح الان
حجم التداول
100
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
10,772,923
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMRN
    -0.06090
    (-8.93%)
    0.62120 USD
    I
    IMGN
    0
    (0%)
    0.000000 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    M
    MRNS
    0.00000
    (0.00%)
    1.40000 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    المزيد
الأخبار
المقالات

العنوان: Immuron Limited

القطاع: Healthcare
الصناعة: Biotechnology
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.